nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Additional considerations for CF nutritional guidelines
|
Siracusa, Christopher |
|
|
22 |
6 |
p. 1133-1134 |
artikel |
2 |
Alterations in lipids after initiation of highly effective modulators in people with cystic fibrosis
|
Despotes, Katherine A. |
|
|
22 |
6 |
p. 1024-1026 |
artikel |
3 |
A pediatric cystic fibrosis arthropathy case who responded to Elexacaftor/Tezacaftor/Ivacaftor therapy
|
Arslan, Meliksah |
|
|
22 |
6 |
p. 1120-1122 |
artikel |
4 |
Association of low-density neutrophils with lung function and disease progression in adult cystic fibrosis
|
Murru, Andréa |
|
|
22 |
6 |
p. 1080-1084 |
artikel |
5 |
Autoimmunity in people with cystic fibrosis
|
Chadwick, Christina |
|
|
22 |
6 |
p. 969-979 |
artikel |
6 |
Body mass index and nutritional intake following Elexacaftor/Tezacaftor/Ivacaftor modulator therapy in adults with cystic fibrosis
|
Caley, L.R. |
|
|
22 |
6 |
p. 1002-1009 |
artikel |
7 |
Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis
|
Stephenson, Kimberly G. |
|
|
22 |
6 |
p. 996-1001 |
artikel |
8 |
Changes in nutrition and growth status in young children in the first 12 weeks of ivacaftor therapy
|
Tindall, Alyssa |
|
|
22 |
6 |
p. 989-995 |
artikel |
9 |
Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation
|
Sadras, Ido |
|
|
22 |
6 |
p. 1062-1069 |
artikel |
10 |
Clinician perspectives on barriers and solutions to symptom management in cystic fibrosis
|
Smirnova, Natalia |
|
|
22 |
6 |
p. 1100-1103 |
artikel |
11 |
Editorial Board
|
|
|
|
22 |
6 |
p. ii |
artikel |
12 |
Hidden CFSPID in CF patient registries? The Italian CF Registry experience
|
Terlizzi, V |
|
|
22 |
6 |
p. 1128-1129 |
artikel |
13 |
Human epididymis protein 4 (HE4) plasma concentration inversely correlates with the improvement of cystic fibrosis lung disease in p.Phe508del-CFTR homozygous cases treated with the CFTR modulator lumacaftor/ivacaftor combination
|
Pócsi, Marianna |
|
|
22 |
6 |
p. 1085-1092 |
artikel |
14 |
Hyperbilirubinemia and Gilbert's syndrome in Cystic Fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor
|
Terlizzi, V. |
|
|
22 |
6 |
p. 1130-1132 |
artikel |
15 |
Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy
|
Yuzyuk, Tatiana |
|
|
22 |
6 |
p. 1027-1035 |
artikel |
16 |
Incidence of fibrosing colonopathy with pancreatic enzyme replacement therapy in patients with cystic fibrosis
|
Chiuve, Stephanie E. |
|
|
22 |
6 |
p. 1017-1023 |
artikel |
17 |
Longitudinal mental health trends in cystic fibrosis
|
Hjelm, Michelle |
|
|
22 |
6 |
p. 1093-1099 |
artikel |
18 |
Manifestation and staging of arthropathy in cystic fibrosis. Defining different stages of cystic fibrosis arthropathy using ultrasound imaging and clinical scoring
|
Holz, F. |
|
|
22 |
6 |
p. 980-988 |
artikel |
19 |
Meconium ileus and pancreatic sufficiency with D1152H mutation: A case report and review of the literature
|
Lang, Emma |
|
|
22 |
6 |
p. 1125-1127 |
artikel |
20 |
News article
|
|
|
|
22 |
6 |
p. 959-960 |
artikel |
21 |
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children
|
Orenti, Annalisa |
|
|
22 |
6 |
p. 1070-1079 |
artikel |
22 |
Red ginseng aqueous extract improves mucociliary transport dysfunction and histopathology in CF rat airways
|
Cho, Do-Yeon |
|
|
22 |
6 |
p. 1113-1119 |
artikel |
23 |
SNSP113 (PAAG) improves mucociliary transport and lung pathology in the Scnn1b-Tg murine model of CF lung disease
|
Harris, Elex S. |
|
|
22 |
6 |
p. 1104-1112 |
artikel |
24 |
Standards for the care of people with cystic fibrosis (CF)
|
Southern, Kevin W |
|
|
22 |
6 |
p. 961-962 |
artikel |
25 |
Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosis
|
Castellani, Carlo |
|
|
22 |
6 |
p. 963-968 |
artikel |
26 |
Successful treatment of distal intestinal obstruction syndrome with N-acetylcysteine and polyethylene glycol via colonoscopy
|
Emelogu, Ikenna K. |
|
|
22 |
6 |
p. 1123-1124 |
artikel |
27 |
The association between gut microbiome and growth in infants with cystic fibrosis
|
Deschamp, AR |
|
|
22 |
6 |
p. 1010-1016 |
artikel |
28 |
The impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis
|
Hergenroeder, Georgene E |
|
|
22 |
6 |
p. 1048-1053 |
artikel |
29 |
The natural history of cystic fibrosis liver disease a prospective cohort study
|
Rowland, Marion |
|
|
22 |
6 |
p. 1054-1061 |
artikel |
30 |
What do people with cystic fibrosis eat? Diet quality, macronutrient and micronutrient intakes (compared to recommended guidelines) in adults with cystic fibrosis–A systematic review
|
Greaney, Cian |
|
|
22 |
6 |
p. 1036-1047 |
artikel |